Abingdon Health PLC (GB:ABDX) has released an update.
Abingdon Health PLC has enhanced its position in the regulatory consultancy sector with the strategic acquisition of IVDeology Holdings Limited, a UK-based firm specializing in regulatory services for the in vitro diagnostics market. The deal, valued at up to £700,000, involves issuing 5 million new shares and incorporates earn-out provisions based on performance. This acquisition is set to fortify Abingdon’s regulatory service offerings amid significant regulatory changes in both the EU and US markets.
For further insights into GB:ABDX stock, check out TipRanks’ Stock Analysis page.
